大博医疗: 第三届董事会第十五次会议决议公告

Core Points - The company held its 15th meeting of the third board of directors on March 24, 2025, where several key resolutions were passed [1][2][4] Group 1: Board Resolutions - The board approved the proposal to supplement independent directors, nominating Wei Zhihua and Lin Hongzhen as candidates [2][3] - The board approved a proposal to apply for a comprehensive credit limit of up to 1.9 billion RMB from financial institutions to support business operations and expansion [3][4] - The board authorized the chairman to handle the credit application and sign relevant contracts [4] - The board approved the use of up to 2 billion RMB of temporarily idle self-owned funds for cash management, allowing investment in high-security, liquid financial products [5] - The board passed a proposal regarding the equity of a subsidiary in which major shareholders are involved, with related directors abstaining from the vote [6] Group 2: Upcoming Meetings - The board proposed to hold the first temporary shareholders' meeting of 2025 on April 9, 2025, to review the submitted proposals [6]